Terms: = Leukemia AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990
21 results:
1. Generation and characterization of iPS cell line (SYSUSHi002-A) from PBMCs of an AML patient with TP53 mutation.
Yuan L; Wang Y; Xie R; Lin D; Wang X
Stem Cell Res; 2023 Dec; 73():103230. PubMed ID: 37890328
[TBL] [Abstract] [Full Text] [Related]
2. MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer.
Alburquerque-Bejar JJ; Navajas-Chocarro P; Saigi M; Ferrero-Andres A; Morillas JM; Vilarrubi A; Gomez A; Mate JL; Munoz-Marmol AM; Romero OA; Blecua P; Davalos V; Esteller M; Pros E; Llabata P; Torres-Diz M; Esteve-Codina A; Sanchez-Cespedes M
Cell Rep Med; 2023 Apr; 4(4):101006. PubMed ID: 37044092
[TBL] [Abstract] [Full Text] [Related]
3. Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia.
Cao Y; Liu Y; Shang L; Chen H; Yue Y; Dong W; Guo Y; Yang H; Yang X; Liu Y; Gu W; Zhang X
Int J Clin Oncol; 2022 Jul; 27(7):1222-1232. PubMed ID: 35536524
[TBL] [Abstract] [Full Text] [Related]
4. STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation.
Kim D; Park G; Huuhtanen J; Ghimire B; Rajala H; Moriggl R; Chan WC; Kankainen M; Myllymäki M; Mustjoki S
Leukemia; 2021 Dec; 35(12):3430-3443. PubMed ID: 34075200
[TBL] [Abstract] [Full Text] [Related]
5. MYC as a target for cancer treatment.
Duffy MJ; O'Grady S; Tang M; Crown J
Cancer Treat Rev; 2021 Mar; 94():102154. PubMed ID: 33524794
[TBL] [Abstract] [Full Text] [Related]
6. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.
Agalliu I; Ortega RA; Luciano MS; Mirelman A; Pont-Sunyer C; Brockmann K; Vilas D; Tolosa E; Berg D; Warø B; Glickman A; Raymond D; Inzelberg R; Ruiz-Martinez J; Mondragon E; Friedman E; Hassin-Baer S; Alcalay RN; Mejia-Santana H; Aasly J; Foroud T; Marder K; Giladi N; Bressman S; Saunders-Pullman R
Mov Disord; 2019 Sep; 34(9):1392-1398. PubMed ID: 31348549
[TBL] [Abstract] [Full Text] [Related]
7. Multiple primary non-breast tumors in breast cancer survivors.
Corso G; Veronesi P; Santomauro GI; Maisonneuve P; Morigi C; Peruzzotti G; Intra M; Sacchini V; Galimberti V
J Cancer Res Clin Oncol; 2018 May; 144(5):979-986. PubMed ID: 29502170
[TBL] [Abstract] [Full Text] [Related]
8. Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.
Schick M; Habringer S; Nilsson JA; Keller U
Br J Haematol; 2017 Dec; 179(5):724-738. PubMed ID: 29171017
[TBL] [Abstract] [Full Text] [Related]
9. Genetics of pleiotropic effects of dexamethasone.
Ramsey LB; Pounds S; Cheng C; Cao X; Yang W; Smith C; Karol SE; Liu C; Panetta JC; Inaba H; Rubnitz JE; Metzger ML; Ribeiro RC; Sandlund JT; Jeha S; Pui CH; Evans WE; Relling MV
Pharmacogenet Genomics; 2017 Aug; 27(8):294-302. PubMed ID: 28628558
[TBL] [Abstract] [Full Text] [Related]
10. Generation of intermediate porcine iPS cells under culture condition favorable for mesenchymal-to-epithelial transition.
Zhang S; Guo Y; Cui Y; Liu Y; Yu T; Wang H
Stem Cell Rev Rep; 2015 Feb; 11(1):24-38. PubMed ID: 25134796
[TBL] [Abstract] [Full Text] [Related]
11. Role of MYC in Medulloblastoma.
Roussel MF; Robinson GW
Cold Spring Harb Perspect Med; 2013 Nov; 3(11):. PubMed ID: 24186490
[TBL] [Abstract] [Full Text] [Related]
12. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma.
Allen TD; Rodriguez EM; Jones KD; Bishop JM
Cancer Res; 2011 Sep; 71(18):6010-8. PubMed ID: 21803744
[TBL] [Abstract] [Full Text] [Related]
13. AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.
Zhong L; Shen H; Huang C; Jing H; Cao D
Toxicol Appl Pharmacol; 2011 Aug; 255(1):40-7. PubMed ID: 21640744
[TBL] [Abstract] [Full Text] [Related]
14. Coexpression of the myc gene family members in human neuroblastoma cell lines.
Hemmi H; Yamada K; Yoon UH; Kato M; Taniguchi F; Tsuchida Y; Shimatake H
Biochem Mol Biol Int; 1995 Aug; 36(6):1135-41. PubMed ID: 8535284
[TBL] [Abstract] [Full Text] [Related]
15. L-myc and N-myc in hematopoietic malignancies.
Hirvonen H; Hukkanen V; Salmi TT; Pelliniemi TT; Alitalo R
Leuk Lymphoma; 1993 Oct; 11(3-4):197-205. PubMed ID: 8260894
[TBL] [Abstract] [Full Text] [Related]
16. Expression of L-myc and N-myc proto-oncogenes in human leukemias and leukemia cell lines.
Hirvonen H; Hukkanen V; Salmi TT; Mäkelä TP; Pelliniemi TT; Knuutila S; Alitalo R
Blood; 1991 Dec; 78(11):3012-20. PubMed ID: 1954386
[TBL] [Abstract] [Full Text] [Related]
17. The myc gene family proteins and their role in transformation and differentiation.
Ingvarsson S
Semin Cancer Biol; 1990 Dec; 1(6):359-69. PubMed ID: 2103508
[TBL] [Abstract] [Full Text] [Related]
18. A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation.
Birrer MJ; Raveh L; Dosaka H; Segal S
Mol Cell Biol; 1989 Jun; 9(6):2734-7. PubMed ID: 2668739
[TBL] [Abstract] [Full Text] [Related]
19. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.
Schütte J; Minna JD; Birrer MJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2257-61. PubMed ID: 2648396
[TBL] [Abstract] [Full Text] [Related]
20. [Translocation t(1; 14) and rearrangement of the gene for the alpha chain of the T-cell receptor in acute T-lymphoblastic leukemia].
Mathieu-Mahul D; Bernheim A; Sigaux F; Daniel MT; Larsen CJ; Berger R
C R Acad Sci III; 1986; 302(14):525-8. PubMed ID: 3085877
[TBL] [Abstract] [Full Text] [Related]
[Next]
